Research Article
The NCEP-ATPIII but not the IDF criteria for the metabolic syndrome identify Type 2 diabetic patients at increased risk of chronic kidney disease

A. O. Y. Luk, R. C. W. Ma, W-Y. So, X-L. Yang, A. P. S. Kong, R. Ozaki, G. T. C. Ko, C-C. Chow, C. S. Cockram, J. C. N. Chan and P. C. Y. Tong

Diabetic Medicine, 2008, 25(12), 1419-1425. DOI: 10.1111/j.1464-5491.2008.02602.x

Abstract

Aim  To examine the association between chronic kidney disease (CKD) and the metabolic syndrome (MetS) using both International Diabetes Federation (IDF) and National Cholesterol Education Program's Adult Treatment Panel III (NCEP-ATPIII) definitions in Chinese subjects with Type 2 diabetes.

Methods  Subjects with Type 2 diabetes were categorized according to the presence or absence of MetS by IDF or NCEP-ATPIII criteria. CKD was considered present if glomerular filtration rate, calculated using the abbreviated equation developed by the Modification of Diet in Renal Disease study with Chinese modification, was < 60 ml/min per 1.73 m2. Multivariate logistic regression analysis of the association between CKD and MetS by either definition was performed.

Results  Of 6350 subjects (mean age 55.1 ± 13.3 years), 3439 (54.2%) and 3204 (50.5%) had MetS by IDF and NCEP-ATPIII definitions, respectively. Using the IDF definition, the presence of MetS was not associated with CKD [odds ratio (OR) 0.96, 95% confidence interval (CI) 0.71, 1.29, P = 0.784]. In contrast, the association with CKD was significant when MetS was defined by the NCEP-ATPIII definition (OR 1.75, 95% CI 1.37, 2.24, P < 0.001). In subjects who did not have MetS (n = 2911) as defined by IDF criteria, 997 fulfilled the MetS criteria of NCEP-ATP III. The association with CKD was stronger, after adjustment for covariates, in these subjects (OR 1.42, 95% CI 1.03, 1.97, P = 0.032) compared with subjects who met IDF criteria of MetS.

Conclusion  In Type 2 diabetes, NCEP-ATPIII, but not the IDF definition of MetS, identifies a subgroup of patients who have a higher risk of CKD.

ASCI-ID: 109-516

View Fulltext

Similar Articles


The high prevalence of unrecognized anaemia in patients with diabetes and chronic kidney disease: a population-based study

Diabetic Medicine, 2008, 25(5), 564-569. DOI: 10.1111/j.1464-5491.2008.02424.x

Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16

Diabetic Medicine, 2008, 25(12), 1426-1432. DOI: 10.1111/j.1464-5491.2008.02592.x

Comparison of the prevalence of chronic kidney disease in Japanese patients with Type 1 and Type 2 diabetes

Diabetic Medicine, 2010, 27(9), 1017-1023. DOI: 10.1111/j.1464-5491.2010.03049.x

Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver

Diabetic Medicine, 2012, 29(2), 220-226. DOI: 10.1111/j.1464-5491.2011.03427.x

The Pro12Ala polymorphism of the PPARG gene is not associated with the metabolic syndrome in an urban population of middle-aged Swedish individuals

Diabetic Medicine, 2008, 25(8), 902-908.

Gender differences in C-reactive protein, interleukin-1 receptor antagonist and adiponectin levels in the metabolic syndrome: a population-based study

Diabetic Medicine, 2008, 25(6), 747-750. DOI: 10.1111/j.1464-5491.2008.02440.x

Relationship between γ-glutamyltransferase and metabolic syndrome in a Korean population

Diabetic Medicine, 2008, 25(4), 469-475. DOI: 10.1111/j.1464-5491.2008.02415.x

Metabolic syndrome and alanine aminotransferase: a global perspective from the NAVIGATOR screening population

Diabetic Medicine, 2009, 26(12), 1204-1211. DOI: 10.1111/j.1464-5491.2009.02864.x

Dietary glycaemic carbohydrate in relation to the metabolic syndrome in adolescents: comparison of different metabolic syndrome definitions

Diabetic Medicine, 2010, 27(7), 770-778. DOI: 10.1111/j.1464-5491.2010.03021.x

Alcohol drinking, the metabolic syndrome and diabetes in a population with high mean alcohol consumption

Diabetic Medicine, 2010, 27(11), 1241-1249. DOI: 10.1111/j.1464-5491.2010.03094.x

Elevated glucose concentrations during an oral glucose tolerance test are associated with the presence of metabolic syndrome in childhood obesity

Diabetic Medicine, 2008, 25(3), 289-295. DOI: 10.1111/j.1464-5491.2007.02380.x

Education eclipses ethnicity in predicting the development of the metabolic syndrome in different ethnic groups in midlife: the Study of Women's Health Across the Nation (SWAN)

Diabetic Medicine, 2008, 25(12), 1390-1399. DOI: 10.1111/j.1464-5491.2008.02596.x

The metabolic syndrome is related to albuminuria in Type 2 diabetes

Diabetic Medicine, 2008, 25(12), 1412-1418. DOI: 10.1111/j.1464-5491.2008.02603.x

The metabolic syndrome: in need of a global mission statement

Diabetic Medicine, 2009, 26(3), 306-309. DOI: 10.1111/j.1464-5491.2009.02681.x

Metabolic syndrome and short-term heart rate variability in young adults

Diabetic Medicine, 2009, 26(4), 354-361. DOI: 10.1111/j.1464-5491.2009.02686.x

Altered respiratory function is associated with increased metabolic risk, independently of adiposity, fitness and physical activity

Diabetic Medicine, 2009, 26(4), 362-369. DOI: 10.1111/j.1464-5491.2009.02689.x

Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review

Diabetic Medicine, 2010, 27(5), 593-597. DOI: 10.1111/j.1464-5491.2010.02998.x

Glycaemic variability using continuous glucose monitoring and endothelial function in the metabolic syndrome and in Type 2 diabetes

Diabetic Medicine, 2010, 27(8), 872-878. DOI: 10.1111/j.1464-5491.2010.03059.x

Association of metabolic syndrome and diabetes with subclinical coronary stenosis and plaque subtypes in middle-aged individuals

Diabetic Medicine, 2011, 28(4), 493-499. DOI: 10.1111/j.1464-5491.2010.03213.x

Metabolic syndrome, impaired fasting glucose and obesity, as predictors of incident diabetes in 14 120 hypertensive patients of ASCOT-BPLA: comparison of their relative predictability using a novel approach

Diabetic Medicine, 2011, 28(8), 941-947. DOI: 10.1111/j.1464-5491.2011.03330.x

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study

Diabetic Medicine, 2011, 28(11), 1343-1351. DOI: 10.1111/j.1464-5491.2011.03360.x

Increased prevalence of chronic kidney disease in patients with Type 1 diabetes and non-alcoholic fatty liver

Diabetic Medicine, 2012, 29(2), 220-226. DOI: 10.1111/j.1464-5491.2011.03427.x

Impact of increased visceral and cardiac fat on cardiometabolic risk and disease

Diabetic Medicine, 2012, 29(5), 622-627. DOI: 10.1111/j.1464-5491.2011.03503.x

Heterogeneity in sex differences in the metabolic syndrome in Dutch white, Surinamese African and South Asian populations

Diabetic Medicine, 2012, 29(9), 1159-1164. DOI: 10.1111/j.1464-5491.2012.03616.x

Depressive symptoms linked to 1-h plasma glucose concentrations during the oral glucose tolerance test in men and women with the metabolic syndrome

Diabetic Medicine, 2014, 31(5), 630-636. DOI: 10.1111/dme.12356

Diagnostic values of different definitions of metabolic syndrome to detect poor health status in Iranian adults without diabetes

Diabetic Medicine, 2014, 31(7), 854-861. DOI: 10.1111/dme.12443

Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials

Diabetic Medicine, 2008, 25(8), 924-932.

Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres

Diabetic Medicine, 2008, 25(4), 427-434. DOI: 10.1111/j.1464-5491.2008.02402.x

Fatty liver is an independent risk factor for the development of Type 2 diabetes in Korean adults

Diabetic Medicine, 2008, 25(4), 476-481. DOI: 10.1111/j.1464-5491.2008.02410.x

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes

Diabetic Medicine, 2007, 24(6), 618-625. DOI: 10.1111/j.1464-5491.2007.02141.x

Rosiglitazone RECORD study: glucose control outcomes at 18 months

Diabetic Medicine, 2007, 24(6), 626-634. DOI: 10.1111/j.1464-5491.2007.02160.x

Lack of association between polymorphisms in the gene encoding protein tyrosine phosphatase 1B (PTPN1) and risk of Type 2 diabetes

Diabetic Medicine, 2007, 24(6), 650-655. DOI: 10.1111/j.1464-5491.2007.02132.x

Interactive effect of retinopathy and macroalbuminuria on all-cause mortality, cardiovascular and renal end points in Chinese patients with Type 2 diabetes mellitus

Diabetic Medicine, 2007, 24(7), 741-746. DOI: 10.1111/j.1464-5491.2007.02145.x

Near patient testing for glycated haemoglobin in people with Type 2 diabetes mellitus managed in primary care: acceptability and satisfaction

Diabetic Medicine, 2007, 24(7), 792-795. DOI: 10.1111/j.1464-5491.2007.02175.x

Service quality for Type 2 diabetes in Australia: the patient perspective

Diabetic Medicine, 2008, 25(5), 612-617. DOI: 10.1111/j.1464-5491.2008.02420.x

Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study

Diabetic Medicine, 2008, 25(10), 1171-1177. DOI: 10.1111/j.1464-5491.2008.02567.x

Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database

Diabetic Medicine, 2009, 26(5), 466-473. DOI: 10.1111/j.1464-5491.2009.02720.x

Modification of diet in renal disease and Cockcroft–Gault formulas do not predict mortality (ZODIAC-6)

Diabetic Medicine, 2009, 26(5), 478-482. DOI: 10.1111/j.1464-5491.2009.02709.x

Individual and contextual factors associated with follow-up use of diabetes self-management education programmes: a multisite prospective analysis

Diabetic Medicine, 2009, 26(5), 510-517. DOI: 10.1111/j.1464-5491.2009.02713.x

Socioeconomic factors related to attendance at a Type 2 diabetes screening programme

Diabetic Medicine, 2009, 26(5), 518-525. DOI: 10.1111/j.1464-5491.2009.02715.x

Impact of high-fat /low-carbohydrate, high-, low-glycaemic index or low-caloric meals on glucose regulation during aerobic exercise in Type 2 diabetes

Diabetic Medicine, 2009, 26(6), 589-595. DOI: 10.1111/j.1464-5491.2009.02734.x

Risk prediction models for the development of diabetes in Mauritian Indians

Diabetic Medicine, 2009, 26(10), 996-1002. DOI: 10.1111/j.1464-5491.2009.02810.x

Increasing trend in the prevalence of Type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao, China

Diabetic Medicine, 2009, 26(12), 1220-1227. DOI: 10.1111/j.1464-5491.2009.02832.x

Which people with Type 2 diabetes achieve good control of intermediate outcomes? Population database study in a UK region

Diabetic Medicine, 2009, 26(12), 1269-1276. DOI: 10.1111/j.1464-5491.2009.02837.x

Moderating effects of coping styles on anxiety and depressive symptoms caused by psychological stress in Chinese patients with Type 2 diabetes

Diabetic Medicine, 2009, 26(12), 1282-1288. DOI: 10.1111/j.1464-5491.2009.02840.x

Diabetes and other glucose metabolism abnormalities in Mexican Zapotec and Mixe Indians

Diabetic Medicine, 2010, 27(4), 412-416. DOI: 10.1111/j.1464-5491.2010.02966.x

Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost

Diabetic Medicine, 2010, 27(6), 679-684. DOI: 10.1111/j.1464-5491.2010.03004.x

The potential impact of using glycated haemoglobin as the preferred diagnostic tool for detecting Type 2 diabetes mellitus

Diabetic Medicine, 2010, 27(7), 762-769. DOI: 10.1111/j.1464-5491.2010.03015.x

Effects of saliva substitutes on oral status in patients with Type 2 diabetes

Diabetic Medicine, 2010, 27(11), 1280-1283. DOI: 10.1111/j.1464-5491.2010.03063.x

Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications

Diabetic Medicine, 2010, 27(2), 136-142. DOI: 10.1111/j.1464-5491.2009.02894.x

Progression to insulin deficiency in Korean patients with Type 2 diabetes mellitus positive for anti-GAD antibody

Diabetic Medicine, 2011, 28(3), 319-324. DOI: 10.1111/j.1464-5491.2010.03186.x

The impact of Type 2 diabetes and microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial disease (SMART) study

Diabetic Medicine, 2008, 25(1), 51-57. DOI: 10.1111/j.1464-5491.2007.02345.x

Differences in height explain gender differences in the response to the oral glucose tolerance test- the AusDiab study

Diabetic Medicine, 2008, 25(3), 296-302. DOI: 10.1111/j.1464-5491.2007.02362.x

Four weeks of near-normalization of blood glucose has no effect on postprandial GLP-1 and GIP secretion, but augments pancreatic B-cell responsiveness to a meal in patients with Type 2 diabetes

Diabetic Medicine, 2008, 25(11), 1268-1275. DOI: 10.1111/j.1464-5491.2008.02579.x

Association between depression and concurrent Type 2 diabetes outcomes varies by diabetes regimen

Diabetic Medicine, 2008, 25(11), 1324-1329. DOI: 10.1111/j.1464-5491.2008.02590.x

Levofloxacin-associated hypoglycaemia complicated by pontine myelinolysis and quadriplegia

Diabetic Medicine, 2008, 25(7), 856-859. DOI: 10.1111/j.1464-5491.2008.02465.x

Genome-wide linkage scans for renal function and albuminuria in Type 2 diabetes mellitus: the Diabetes Heart Study

Diabetic Medicine, 2008, 25(3), 268-276. DOI: 10.1111/j.1464-5491.2007.02361.x

Biomedical, lifestyle and psychosocial characteristics of people newly diagnosed with Type 2 diabetes: baseline data from the DESMOND randomized controlled trial

Diabetic Medicine, 2008, 25(12), 1454-1461. DOI: 10.1111/j.1464-5491.2008.02620.x

Improved treatment satisfaction and weight-related quality of life with exenatide once weekly or twice daily

Diabetic Medicine, 2009, 26(7), 722-728. DOI: 10.1111/j.1464-5491.2009.02752.x

High prevalence of diabetes and impaired fasting glucose in urban Latin America: the CARMELA Study

Diabetic Medicine, 2009, 26(9), 864-871. DOI: 10.1111/j.1464-5491.2009.02795.x

Risk factors associated with the dramatic increase in the prevalence of diabetes in the adult Chinese population in Qingdao, China

Diabetic Medicine, 2009, 26(9), 855-863. DOI: 10.1111/j.1464-5491.2009.02791.x

Smoking prevalence in Type 2 diabetes: results of the Study of Health in Pomerania (SHIP) and the German National Health Interview and Examination Survey (GNHIES)

Diabetic Medicine, 2009, 26(8), 791-797. DOI: 10.1111/j.1464-5491.2009.02784.x

Prevalence of GORD (gastro-oesophageal reflux disease) in Type 2 diabetes and a comparison of clinical profiles between diabetic patients with and without GORD

Diabetic Medicine, 2009, 26(3), 228-233. DOI: 10.1111/j.1464-5491.2009.02671.x

Cigarette smoking and proteinuria in Taiwanese men with Type 2 diabetes mellitus

Diabetic Medicine, 2010, 27(3), 295-302. DOI: 10.1111/j.1464-5491.2010.02947.x

Are clinical practical guidelines (CPGs) useful for health services and health workforce planning? A critique of diabetes CPGs

Diabetic Medicine, 2010, 27(5), 570-577. DOI: 10.1111/j.1464-5491.2010.02981.x

The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting

Diabetic Medicine, 2010, 27(8), 887-895. DOI: 10.1111/j.1464-5491.2010.03037.x

Comparison of the efficacy and safety of tramadol/acetaminophen combination therapy and gabapentin in the treatment of painful diabetic neuropathy

Diabetic Medicine, 2010, 27(9), 1033-1040. DOI: 10.1111/j.1464-5491.2010.03054.x

Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes?

Diabetic Medicine, 2010, 27(12), 1341-1349. DOI: 10.1111/j.1464-5491.2010.03137.x

The association between the spatial QRS-T angle with cardiac autonomic neuropathy in subjects with Type 2 diabetes mellitus

Diabetic Medicine, 2010, 27(12), 1420-1429. DOI: 10.1111/j.1464-5491.2010.03120.x

Prediction models for incident Type 2 diabetes mellitus in the older population: KORA S4/F4 cohort study

Diabetic Medicine, 2010, 27(10), 1116-1123. DOI: 10.1111/j.1464-5491.2010.03065.x

Comparison of the prevalence of chronic kidney disease in Japanese patients with Type 1 and Type 2 diabetes

Diabetic Medicine, 2010, 27(9), 1017-1023. DOI: 10.1111/j.1464-5491.2010.03049.x

Perceived and actual diabetes risk in the Chinese and Hispanic/Latino communities in Portland, OR, USA

Diabetic Medicine, 2011, 28(6), 658-667. DOI: 10.1111/j.1464-5491.2010.03193.x

The humoral immune response to the inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with Type 2 diabetes mellitus in Korea

Diabetic Medicine, 2011, 28(7), 815-817. DOI: 10.1111/j.1464-5491.2011.03255.x

Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus

Diabetic Medicine, 2011, 28(7), 856-864. DOI: 10.1111/j.1464-5491.2011.03240.x

Oral anti-diabetic drugs for the prevention of Type 2 diabetes

Diabetic Medicine, 2011, 28(8), 948-964. DOI: 10.1111/j.1464-5491.2011.03303.x

Use of dynamic contrast-enhanced magnetic resonance imaging to evaluate the microcirculation of lower extremity muscles in patients with Type 2 diabetes

Diabetic Medicine, 2011, 28(5), 618-621. DOI: 10.1111/j.1464-5491.2011.03244.x

Screening for Type 2 diabetes. Lessons from the ADDITION-Europe study

Diabetic Medicine, 2011, 28(11), 1416-1424. DOI: 10.1111/j.1464-5491.2011.03365.x

Alcohol consumption and risk of pre-diabetes and type 2 diabetes development in a Swedish population

Diabetic Medicine, 2012, 29(4), 441-452. DOI: 10.1111/j.1464-5491.2011.03450.x

Prevalence of abnormal plasma liver enzymes in older people with Type 2 diabetes

Diabetic Medicine, 2012, 29(4), 488-491. DOI: 10.1111/j.1464-5491.2011.03492.x

Types of smokers in a community sample of individuals with Type 2 diabetes: a latent class analysis

Diabetic Medicine, 2012, 29(5), 586-592. DOI: 10.1111/j.1464-5491.2011.03493.x

Health-related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population-based surveys in Germany

Diabetic Medicine, 2012, 29(5), 646-653. DOI: 10.1111/j.1464-5491.2011.03465.x

Vitamin D and diabetes in Koreans: analyses based on the Fourth Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2009

Diabetic Medicine, 2012, 29(8), 1003-1010. DOI: 10.1111/j.1464-5491.2012.03575.x

Increased apoB/A-I ratio independently associated with Type 2 diabetes mellitus: cross-sectional study in a Korean population

Diabetic Medicine, 2012, 29(9), 1165-1170. DOI: 10.1111/j.1464-5491.2012.03622.x

Serum 1,5-anhydroglucitol is associated with diabetic retinopathy in Type 2 diabetes

Diabetic Medicine, 2012, 29(9), 1184-1190. DOI: 10.1111/j.1464-5491.2012.03613.x